In contrast, the current study shows an increase in lactate but a decrease in VEGF and no significant effect on ECM degradation in SCC, indicating that SASP tumor cells are undergoing changes that could ultimately determine the fate of non-cancerous tumor cells in vivo. This evidence concerns the gene VEGFA and neoplasm.